Business Description
Pharmagreen Biotech Inc
NAICS : 325414
SIC : 2834
ISIN : US71716C1099
Description
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.59 | |||||
9-Day RSI | 43.68 | |||||
14-Day RSI | 42.39 | |||||
3-1 Month Momentum % | -30.71 | |||||
6-1 Month Momentum % | -55.91 | |||||
12-1 Month Momentum % | 7.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -6850 | |||||
OCF Margin % | -6850 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -1.54 | |||||
EV-to-EBITDA | -1.54 | |||||
EV-to-Revenue | 311 | |||||
EV-to-FCF | -4.54 | |||||
Earnings Yield (Greenblatt) % | -64.94 | |||||
FCF Yield % | -22.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PHBI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmagreen Biotech Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.002 | ||
| EPS (TTM) ($) | - | ||
| Beta | 1.5782 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.89 | ||
| Volatility % | 94.73 | ||
| 14-Day RSI | 42.39 | ||
| 14-Day ATR ($) | 0.000195 | ||
| 20-Day SMA ($) | 0.000939 | ||
| 12-1 Month Momentum % | 7.78 | ||
| 52-Week Range ($) | 0.0005 - 0.0035 | ||
| Shares Outstanding (Mil) | 691.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmagreen Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmagreen Biotech Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2026-11-26 | In 148 days | ||
| Third quarter earnings results for 2026 | 2026-07-31 | In 30 days | ||
| Second quarter earnings results for 2026 | 2026-05-15 | 0.00 (+17.24%) | ||
| First quarter earnings results for 2026 | 2026-02-23 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2025-11-26 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-08-01 | 0.00 (-4.44%) | ||
| Second quarter earnings results for 2025 | 2025-05-13 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-02-12 | 0.00 (+2.94%) | ||
| Annual report for 2024 | 2024-12-10 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2024-08-12 | 0.00 (+0.00%) |
Show
Entries
Pharmagreen Biotech Inc Frequently Asked Questions
What is Pharmagreen Biotech Inc(PHBI)'s stock price today?
The current price of PHBI is $0.00. The 52 week high of PHBI is $0.00 and 52 week low is $0.00.
When is next earnings date of Pharmagreen Biotech Inc(PHBI)?
The next earnings date of Pharmagreen Biotech Inc(PHBI) is 2026-07-31 Est..
Does Pharmagreen Biotech Inc(PHBI) pay dividends? If so, how much?
Pharmagreen Biotech Inc(PHBI) does not pay dividend.
Guru Commentaries on OTCPK:PHBI
No articles.
Press Release
Articles on Pharmagreen Biotech Inc
No articles.